tiprankstipranks

Scott Kellen Insider Profile

11 Followers
Scott Kellen, COO, CFO, VP of Finance & Secy at Kips Bay Medical, holds 32.29K shares in Diamedica Therapeutics (Ticker: DMAC), holds ― shares in Kips Bay Medical (Ticker: KIPS). Most recently, Scott Kellen Bought ― shares of Diamedica Therapeutics on Jun 26, 2023 for an estimated value of 39.10K.
tipranks
Scott Kellen

Scott Kellen
Kips Bay Medical (KIPS)
COO, CFO, VP of Finance & Secy

Ranked #17,381 out of 98,624 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+19.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$97K
100.00%
A breakdown of Scott Kellen's holdings

Insider Roles

Diamedica Therapeutics
(DMAC)
CFO & Sec
Roles that Scott Kellen holds in companies

Most Profitable Insider Trade

Stock:
Diamedica Therapeutics
(DMAC)
Rating:Informative Buy
Date:Aug 19, 2019 - Aug 19, 2020
Return:+111.90%
The most profitable trade made by Scott Kellen

Scott Kellen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KIPS
Kips Bay Medical
Sep 03, 2013
Informative Buy
7.77K
Diamedica Therapeutics
Jun 26, 2023
CFO & Sec
Informative Buy
39.10K
$96.87K
List of latest transactions for each holding click on a transaction to see Scott Kellen's performance on stock

Scott Kellen insider profile FAQ

What is the percentage of profitable transactions made by Scott Kellen?
The percentage of profitable transactions made by Scott Kellen is 60%.
    What is the average return per transaction made by Scott Kellen?
    The average return per transaction made by Scott Kellen is 19.30%.
      What stocks does Scott Kellen hold?
      Scott Kellen holds: KIPS, DMAC stocks.
        What was Scott Kellen’s latest transaction?
        Scott Kellen latest transaction was an Informative Buy of $39.10K.
          What was Scott Kellen's most profitable transaction?
          Scott Kellen’s most profitable transaction was an Informative Buy of DMAC stock on August 19, 2019. The return on the trade was 111.90%.
            What is Scott Kellen's role in Kips Bay Medical?
            Scott Kellen's role in Kips Bay Medical is COO, CFO, VP of Finance & Secy.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.